EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical application of nanopore-targeted sequencing technology in bronchoalveolar lavage fluid from patients with pulmonary infections

Jiayuan Ye iD, Kai Huang, Yaojiang Xu, Nan Chen, Yifei Tu, Jing Huang, Longfei Shao, Weiliang Kong iD, Dongdong Zhao iD, Yilian Xie iD

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.00026-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Jiayuan Ye und 9 weiteren Autor:innen. Beteiligte Einrichtung: Health Science Center, Ningbo University, Ningbo, Zhejiang, China. Hauptthemen laut MEDLINE: Bronchoalveolar Lavage Fluid, High-Throughput Nucleotide Sequencing, Respiratory Tract Infections. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rapid and effective identification of pathogens in patients with pulmonary infections has posed a persistent challenge in medicine, with conventional microbiological tests (CMTs) proving time-consuming and less sensitive, hindering early diagnosis of respiratory infections. While there has been some research on the clinical performance of targeted sequencing technologies, limited focus has been directed toward bronchoalveolar lavage fluid (BALF). This study primarily evaluates the pathogen detection capabilities of nanopore-targeted sequencing (NTS) in BALF, providing a comprehensive analysis. The retrospective study, spanning from January 2022 to November 2023, includes 223 patients exclusively sourced from a single center. We conducted a detailed comparative analysis among NTS, targeted next-generation sequencing (tNGS), and CMTs. Initially, we compared the detection capabilities of NTS and tNGS and found no significant differences in their sensitivity and specificity. Specifically, we observed that the sensitivity of NTS was significantly higher than that of CMTs (74.83% vs 33.11%, P < 0.001). Furthermore, NTS exhibited a higher positivity rate in common pulmonary infections (62.88% vs. 23.48%) and in clinically suspected tuberculosis patients compared to CMTs (87.18% vs. 48.72%). Additionally, NTS showed less susceptibility to antibiotic interference, indicating a more sensitive detection capability, especially in detecting fastidious organisms. It complements GeneXpert in tuberculosis diagnosis and offers excellent advantages in identifying pathogens challenging for CMTs, such as non-tuberculous mycobacteria and viruses. Moreover, NTS significantly shortens the reporting time and is only a quarter of the cost of metagenomic next-generation sequencing. Clearly, NTS can facilitate faster and more cost-effective early diagnosis of respiratory infections. IMPORTANCE This study holds paramount significance in advancing the field of respiratory infection diagnostics. By assessing the pathogen detection capabilities in bronchoalveolar lavage fluid (BALF) of patients with pulmonary infections, we illuminate the promising potential of nanopore-targeted sequencing (NTS). The findings underscore NTS as a comparable yet distinct alternative to traditional methods like comprehensive conventional microbiological tests (CMTs). Notably, NTS demonstrates a pivotal edge, expanding the spectrum of identified pathogens, particularly excelling in the detection of challenging entities like non-tuberculous mycobacteria and viruses. The study also highlights the complementary role of NTS alongside GeneXpert in the identification of tuberculosis, providing a comprehensive overview of the diagnostic landscape for respiratory infections. This insight carries significant implications for clinicians seeking rapid, cost-effective, and accurate diagnostic tools in the realm of pulmonary infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bronchoalveolar Lavage FluidHigh-Throughput Nucleotide SequencingRespiratory Tract InfectionsHumansMaleFemaleMiddle AgedRetrospective StudiesAgedNanopore SequencingAdultNanoporesBacteriaSensitivity and SpecificityAged, 80 and over

Stichwörter der Autor:innen

bronchoalveolar lavage fluidclinical diagnosisnanoporepathogen detectionpulmonary infection

Autor:innen und Institutionen

  • Health Science Center, Ningbo University, Ningbo, Zhejiang, China.
  • Department of Infectious Diseases, Shangyu People's Hospital Of Shaoxing, Shaoxing, Zhejiang, China.
  • Department of General Medicine, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China.
  • Department of Radiology, Shangyu People's Hospital Of Shaoxing, Shaoxing, Zhejiang, China.
  • Department of Respiratory, Shangyu People's Hospital Of Shaoxing, Shaoxing, Zhejiang, China.
  • Key Laboratory of Digital Technology in Medical Diagnostics of Zhejiang Province, Dian Diagnostics Group Co., Ltd., Hangzhou, Zhejiang, China.

ORCID-Profile: Jiayuan Ye, Weiliang Kong, Dongdong Zhao, Yilian Xie

Zitieren

APA

Ye, J., Huang, K., Xu, Y., Chen, N., Tu, Y., Huang, J., Shao, L., Kong, W., Zhao, D., & Xie, Y. (2024). Clinical application of nanopore-targeted sequencing technology in bronchoalveolar lavage fluid from patients with pulmonary infections. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00026-24

Vancouver

Ye J, Huang K, Xu Y, Chen N, Tu Y, Huang J, et al. Clinical application of nanopore-targeted sequencing technology in bronchoalveolar lavage fluid from patients with pulmonary infections. Microbiology Spectrum. 2024. doi:10.1128/spectrum.00026-24

BibTeX
@article{Ye2024,
  author = {Ye, Jiayuan and Huang, Kai and Xu, Yaojiang and Chen, Nan and Tu, Yifei and Huang, Jing and Shao, Longfei and Kong, Weiliang and Zhao, Dongdong and Xie, Yilian},
  title = {Clinical application of nanopore-targeted sequencing technology in bronchoalveolar lavage fluid from patients with pulmonary infections},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.00026-24}
}
Kostenlos starten →